Literature DB >> 11583954

Skeletal muscle fibers express major histocompatibility complex class II antigens independently of inflammatory infiltrates in inflammatory myopathies.

P Englund1, E Lindroos, I Nennesmo, L Klareskog, I E Lundberg.   

Abstract

The aim of our study was to address the question of whether muscle fibers express major histocompatibility complex (MHC) class II in inflammatory myopathies. For this purpose we performed a systematic study of MHC class II antigen expression on muscle fiber membranes in muscle tissue from polymyositis and dermatomyositis patients in various stages of disease activity. Thirty-two patients with classical clinical signs of myositis were divided into subgroups depending on duration of clinical signs of myositis and presence or absence of inflammatory infiltrates in muscle tissue. Immunohistochemistry as well as double-immunofluorescence stainings were used to identify the presence of MHC class II in muscle tissue. MHC class I was included for comparison. Quantification of positive staining was performed using an image analysis system in addition to evaluation by manual microscopic scoring and laser confocal microscopy. It was demonstrated that a significant proportion of skeletal muscle fibers in inflammatory myopathies express MHC class II as well as MHC class I and that MHC antigen expression is independent of the inflammatory cell infiltration. Furthermore, there were no differences in staining pattern between polymyositis and dermatomyositis patients. Our results indicate that MHC class II and MHC class I molecules may be involved in initiating and maintaining the pathological condition in myositis rather than only being a consequence of a preceding local inflammation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11583954      PMCID: PMC1850491          DOI: 10.1016/S0002-9440(10)62513-8

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  40 in total

Review 1.  Polymyositis and dermatomyositis (first of two parts).

Authors:  A Bohan; J B Peter
Journal:  N Engl J Med       Date:  1975-02-13       Impact factor: 91.245

Review 2.  Polymyositis and dermatomyositis (second of two parts).

Authors:  A Bohan; J B Peter
Journal:  N Engl J Med       Date:  1975-02-20       Impact factor: 91.245

3.  Increased expression of interleukin 1alpha and MHC class I in muscle tissue of patients with chronic, inactive polymyositis and dermatomyositis.

Authors:  P Nyberg; A L Wikman; I Nennesmo; I Lundberg
Journal:  J Rheumatol       Date:  2000-04       Impact factor: 4.666

4.  Expression of HLA-DR and its enhancing molecules in muscle fibers in polymyositis.

Authors:  A Inukai; S Kuru; Y Liang; A Takano; Y Kobayashi; M Sakai; M Doyu; G Sobue
Journal:  Muscle Nerve       Date:  2000-03       Impact factor: 3.217

5.  "Semi-open" muscle biopsy technique. A simple outpatient procedure.

Authors:  K G Henriksson
Journal:  Acta Neurol Scand       Date:  1979-06       Impact factor: 3.209

6.  The effect of cytokines on the expression of MHC antigens and ICAM-1 by normal and transformed synoviocytes.

Authors:  I P Wicks; T Leizer; S O Wawryk; J R Novotny; J Hamilton; G Vitti; A W Boyd
Journal:  Autoimmunity       Date:  1992       Impact factor: 2.815

7.  IL-1 alpha induced, TNF alpha mediated HLA class II (DR) antigen up-regulation in a human ductal breast carcinoma cell line ZR-75-1.

Authors:  P Speiser; R Zeillinger; C Wiltschke; J Sedlák; B Chorváth
Journal:  Neoplasma       Date:  1993       Impact factor: 2.575

8.  Modulation of MHC class II antigen expression in human myoblasts after treatment with IFN-gamma.

Authors:  R Mantegazza; S M Hughes; D Mitchell; M Travis; H M Blau; L Steinman
Journal:  Neurology       Date:  1991-07       Impact factor: 9.910

9.  Vacuolar myositis with expression of both MHC class I and class II antigens on skeletal muscle fibers.

Authors:  I Higuchi; M Nerenberg; T Ijichi; H Fukunaga; K Arimura; F Usuki; M Kuriyama; M Osame
Journal:  J Neurol Sci       Date:  1991-11       Impact factor: 3.181

10.  The role of cytokines in polymyositis: interferon-gamma induces class II and enhances class I major histocompatibility complex antigen expression on cultured human muscle cells.

Authors:  A E Kalovidouris
Journal:  J Lab Clin Med       Date:  1992-08
View more
  38 in total

1.  The molecular basis of skeletal muscle weakness in a mouse model of inflammatory myopathy.

Authors:  William Coley; Sree Rayavarapu; Gouri S Pandey; Richard L Sabina; Jack H Van der Meulen; Beryl Ampong; Robert L Wortmann; Rashmi Rawat; Kanneboyina Nagaraju
Journal:  Arthritis Rheum       Date:  2012-11

Review 2.  Treatment in myositis.

Authors:  Chester V Oddis; Rohit Aggarwal
Journal:  Nat Rev Rheumatol       Date:  2018-03-29       Impact factor: 20.543

Review 3.  The Immune Response and the Pathogenesis of Idiopathic Inflammatory Myositis: a Critical Review.

Authors:  Angela Ceribelli; Maria De Santis; Natasa Isailovic; M Eric Gershwin; Carlo Selmi
Journal:  Clin Rev Allergy Immunol       Date:  2017-02       Impact factor: 8.667

Review 4.  Pathogenesis of idiopathic inflammatory myopathies.

Authors:  Cecilia Grundtman; Ingrid E Lundberg
Journal:  Curr Rheumatol Rep       Date:  2006-06       Impact factor: 4.592

5.  Myopathy with antibodies to the signal recognition particle: clinical and pathological features.

Authors:  T Miller; M T Al-Lozi; G Lopate; A Pestronk
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-10       Impact factor: 10.154

6.  Immune responses to intramuscular administration of alipogene tiparvovec (AAV1-LPL(S447X)) in a phase II clinical trial of lipoprotein lipase deficiency gene therapy.

Authors:  Valerie Ferreira; Jaap Twisk; Karin Kwikkers; Eleonora Aronica; Diane Brisson; Julie Methot; Harald Petry; Daniel Gaudet
Journal:  Hum Gene Ther       Date:  2014-02-28       Impact factor: 5.695

Review 7.  Dermatomyositis, complicated with pneumomediastinum, successfully treated with cyclosporine A: a case report and review of literature.

Authors:  Hui-Jung Kim; Yun-Kyung Hong; Wan-Hee Yoo
Journal:  Rheumatol Int       Date:  2008-12-18       Impact factor: 2.631

8.  Upregulation of MHC class I in transgenic mice results in reduced force-generating capacity in slow-twitch muscle.

Authors:  Stina Salomonsson; Cecilia Grundtman; Shi-Jin Zhang; Johanna T Lanner; Charles Li; Abram Katz; Lucy R Wedderburn; Kanneboyina Nagaraju; Ingrid E Lundberg; Håkan Westerblad
Journal:  Muscle Nerve       Date:  2009-05       Impact factor: 3.217

Review 9.  Perspective on Adeno-Associated Virus Capsid Modification for Duchenne Muscular Dystrophy Gene Therapy.

Authors:  Michael E Nance; Dongsheng Duan
Journal:  Hum Gene Ther       Date:  2015-10-15       Impact factor: 5.695

10.  Differential immunohistological features of inflammatory myopathies and dysferlinopathy.

Authors:  Jae-Hwan Choi; Yeong-Eun Park; Sung-Il Kim; Jeong-Il Kim; Chang-Hoon Lee; Kyu-Hyun Park; Dae-Seong Kim
Journal:  J Korean Med Sci       Date:  2009-11-07       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.